Replies to post #8011 on BioCurex, Inc.(fka BOCX)

[bamboojoe]

gunnar, actually you are reading too much into that. The lab based test is still on track. I would suspect that a second licensee has emerged that wants to pursue the office based test. All is prgressing nicely. Don't let your mind over work like goldseekers and come up with wrong conclusions.

[tommyb]

Why all the negativity already? BOCX is simply developing various applications for their RECAF technology, which is what they have told us they were going to do all along. They talked about developing a "pregnancy-like" RECAF test quite some time ago (I think it might have been during Erthang's original interview with Dr. Moro). Well, that time has now arrived. For better or worse, this kind of announcement is something that the mainstream media just might pick up on. I think that would be a good thing in the short term, as it might lift the SP up to a more appropriate level and allow BOCX to strengthen financially (with some dilution, of course).

It seems obvious to me that the work done in developing the colorimetric test can now be applied to the development of a "point-of-care" RECAF test. Why wouldn't they do this? This is a potentially fantastic development. Granted, it all comes down to how well the RECAF technology works in detecting cancer, but I'm into the stock because it sure looks like it could be effective. What I'm really interested in seeing now is some real world results from their collaboration with the Blohkin Cancer Center.

[longterm42]

gunnar. do you expect BOCX to sit and do nothing while waiting for abbott to complete their work? on the contrary, BOCX is bussy working on other types of tests and possible treatments. A VERY "GREEN" FLAG FOR ME. you sound like an apprentice of GS.

[Gold Seeker]

Gunnar, I think you are more correct than any so far this morning concerning the press release. It would be great if I am wrong and this new concept would sell a ton of tests but I am of the opinion that this release and the small cap comments are in the order of "fluff" to get the stock price up. They probably do not want to dilute below 50 cents and they need to have the price up to attract a placement.

The problem is that "fluff" doesn't hack it any more. To get the stock price up is going to take something much more substantial than wild self generated market projections of a billion dollars. I remember reading a press release from 2001 stating histo-recaf would address a 2 billion dollar market.